Literature DB >> 10798444

Gene structure and chromosomal assignment of mouse GITR, a member of the tumor necrosis factor/nerve growth factor receptor family.

G Nocentini1, A Bartoli, S Ronchetti, L Giunchi, A Cupelli, D Delfino, G Migliorati, C Riccardi.   

Abstract

GITR is a type I transmembrane protein that belongs to the tumor necrosis factor/nerve growth factor receptor (TNF/NGFR) family. This receptor is preferentially expressed in activated T lymphocytes and may function as signaling molecule during T-cell development. In the present study, we examined the genomic organization of the entire mouse GITR (mGITR) gene. The gene spans a 2543-bp region and consists of five exons (with a length ranging from 88 bp to 395 bp) and four introns (67 bp to 778 bp). In agreement with GITR expression in activated T cells, consensus elements for transcription factors involved in T-cell development and activation were identified in the 5' flanking region, including a consensus element for NF-kappaB. Two highly significant binding sites for MyoD and one binding site for myogenin were also found, suggesting involvement of GITR in muscle development. The mGITR gene contains 17 transcription initiation sites distributed over a 76-bp region, all used with the same frequency. We localized mGITR to the murine chromosome 4 (E region), where other 4 TNF/NGFR members localize, including m4-1BB and mOX40. These results further indicate that GITR shares several features with OX40, 4-1BB, and CD27, suggesting the existence of a new subfamily of the TNFR family, as also confirmed by the similarity of their cytoplasmic domains.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10798444     DOI: 10.1089/104454900314474

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  11 in total

1.  The glucocorticoid-induced tumor necrosis factor receptor-related gene modulates the response to Candida albicans infection.

Authors:  Massimiliano Agostini; Elio Cenci; Eva Pericolini; Giuseppe Nocentini; Giovanni Bistoni; Anna Vecchiarelli; Carlo Riccardi
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

Review 2.  TNF superfamily: costimulation and clinical applications.

Authors:  Dass S Vinay; Byoung S Kwon
Journal:  Cell Biol Int       Date:  2009-02-20       Impact factor: 3.612

Review 3.  The promise and challenges of immune agonist antibody development in cancer.

Authors:  Patrick A Mayes; Kenneth W Hance; Axel Hoos
Journal:  Nat Rev Drug Discov       Date:  2018-06-15       Impact factor: 84.694

Review 4.  The role of tumor necrosis factor receptor superfamily members in mammalian brain development, function and homeostasis.

Authors:  Jason P Twohig; Simone M Cuff; Audrey A Yong; Eddie C Y Wang
Journal:  Rev Neurosci       Date:  2011-08-24       Impact factor: 4.353

5.  GITR expression on T-cell receptor-stimulated human CD8 T cell in a JNK-dependent pathway.

Authors:  Subhasis Chattopadhyay; Nitya G Chakraborty
Journal:  Indian J Hum Genet       Date:  2009-09

6.  Murine B cell development and antibody responses to model antigens are not impaired in the absence of the TNF receptor GITR.

Authors:  Lenka Sinik Teodorovic; Carlo Riccardi; Raul M Torres; Roberta Pelanda
Journal:  PLoS One       Date:  2012-02-06       Impact factor: 3.240

7.  PKC-ѳ is dispensable for OX40L-induced TCR-independent Treg proliferation but contributes by enabling IL-2 production from effector T-cells.

Authors:  Khaled Alharshawi; Alejandra Marinelarena; Prabhakaran Kumar; Osama El-Sayed; Palash Bhattacharya; Zuoming Sun; Alan L Epstein; Ajay V Maker; Bellur S Prabhakar
Journal:  Sci Rep       Date:  2017-07-26       Impact factor: 4.379

8.  Structural basis for ligand-mediated mouse GITR activation.

Authors:  Zhaocai Zhou; Yukiko Tone; Xiaomin Song; Keiji Furuuchi; James D Lear; Herman Waldmann; Masahide Tone; Mark I Greene; Ramachandran Murali
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-04       Impact factor: 11.205

9.  OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection.

Authors:  Silvia Piconese; Barbara Valzasina; Mario P Colombo
Journal:  J Exp Med       Date:  2008-03-24       Impact factor: 14.307

10.  GITR activation induces an opposite effect on alloreactive CD4(+) and CD8(+) T cells in graft-versus-host disease.

Authors:  Stephanie J Muriglan; Teresa Ramirez-Montagut; Onder Alpdogan; Thomas W Van Huystee; Jeffrey M Eng; Vanessa M Hubbard; Adam A Kochman; Kartono H Tjoe; Carlo Riccardi; Pier Paolo Pandolfi; Shimon Sakaguchi; Alan N Houghton; Marcel R M Van Den Brink
Journal:  J Exp Med       Date:  2004-07-12       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.